0001209191-18-045455.txt : 20180803
0001209191-18-045455.hdr.sgml : 20180803
20180803212859
ACCESSION NUMBER: 0001209191-18-045455
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180801
FILED AS OF DATE: 20180803
DATE AS OF CHANGE: 20180803
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dispersyn Gerrit
CENTRAL INDEX KEY: 0001704417
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36304
FILM NUMBER: 18993333
MAIL ADDRESS:
STREET 1: 257 SIMARANO DRIVE, SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RXi Pharmaceuticals Corp
CENTRAL INDEX KEY: 0001533040
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 257 SIMARANO DRIVE
STREET 2: SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
BUSINESS PHONE: (508) 767-3861
MAIL ADDRESS:
STREET 1: 257 SIMARANO DRIVE
STREET 2: SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-08-01
0
0001533040
RXi Pharmaceuticals Corp
RXII
0001704417
Dispersyn Gerrit
C/O 257 SIMARANO DRIVE, SUITE 101
MARLBOROUGH
MA
01752
0
1
0
0
Chief Development Officer
Common Stock
2018-08-01
4
A
0
16000
0.00
A
16350
D
Stock option (right to buy)
1.79
2018-08-01
4
A
0
16000
0.00
A
2028-08-01
Common stock
16000
16000
D
Represents shares underlying a restricted stock unit, which shares will vest in four equal annual installments.
The stock option will vest in four equal annual installments.
Caitlin Kontulis, attorney-in-fact
2018-08-03